Medical Care
Global Weight Loss Therapeutics Market Research Report 2025
- Sep 18, 25
- ID: 507544
- Pages: 90
- Figures: 81
- Views: 14
This report aims to provide a comprehensive presentation of the global market for Weight Loss Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Weight Loss Therapeutics.
The Weight Loss Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Weight Loss Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Weight Loss Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai
Segment by Type
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns
Segment by Application
Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Weight Loss Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Weight Loss Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Weight Loss Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Weight Loss Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai
Segment by Type
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns
Segment by Application
Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Weight Loss Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Appetite Suppression
1.2.3 Increasing Body Metabolism
1.2.4 Interfering with the Digestion Absorption Patterns
1.3 Market by Application
1.3.1 Global Weight Loss Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Retail Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Weight Loss Therapeutics Market Perspective (2020-2031)
2.2 Global Weight Loss Therapeutics Growth Trends by Region
2.2.1 Global Weight Loss Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Weight Loss Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Weight Loss Therapeutics Market Dynamics
2.3.1 Weight Loss Therapeutics Industry Trends
2.3.2 Weight Loss Therapeutics Market Drivers
2.3.3 Weight Loss Therapeutics Market Challenges
2.3.4 Weight Loss Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Weight Loss Therapeutics Players by Revenue
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Weight Loss Therapeutics Revenue
3.4 Global Weight Loss Therapeutics Market Concentration Ratio
3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2024
3.5 Global Key Players of Weight Loss Therapeutics Head office and Area Served
3.6 Global Key Players of Weight Loss Therapeutics, Product and Application
3.7 Global Key Players of Weight Loss Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Weight Loss Therapeutics Breakdown Data by Type
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2026-2031)
5 Weight Loss Therapeutics Breakdown Data by Application
5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Weight Loss Therapeutics Market Size (2020-2031)
6.2 North America Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Weight Loss Therapeutics Market Size by Country (2020-2025)
6.4 North America Weight Loss Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Weight Loss Therapeutics Market Size (2020-2031)
7.2 Europe Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Weight Loss Therapeutics Market Size by Country (2020-2025)
7.4 Europe Weight Loss Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Weight Loss Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Weight Loss Therapeutics Market Size (2020-2031)
9.2 Latin America Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Weight Loss Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Weight Loss Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Weight Loss Therapeutics Introduction
11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Weight Loss Therapeutics Introduction
11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2020-2025)
11.3.5 Novo Nordisk Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2020-2025)
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Orexigen Therapeutics
11.5.1 Orexigen Therapeutics Company Details
11.5.2 Orexigen Therapeutics Business Overview
11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2020-2025)
11.5.5 Orexigen Therapeutics Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Weight Loss Therapeutics Introduction
11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Weight Loss Therapeutics Introduction
11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Biocon
11.9.1 Biocon Company Details
11.9.2 Biocon Business Overview
11.9.3 Biocon Weight Loss Therapeutics Introduction
11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2020-2025)
11.9.5 Biocon Recent Development
11.10 VIVUS
11.10.1 VIVUS Company Details
11.10.2 VIVUS Business Overview
11.10.3 VIVUS Weight Loss Therapeutics Introduction
11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2020-2025)
11.10.5 VIVUS Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2020-2025)
11.11.5 Eli Lilly Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Weight Loss Therapeutics Introduction
11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2020-2025)
11.12.5 Amgen Recent Development
11.13 Zafgen
11.13.1 Zafgen Company Details
11.13.2 Zafgen Business Overview
11.13.3 Zafgen Weight Loss Therapeutics Introduction
11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2020-2025)
11.13.5 Zafgen Recent Development
11.14 Roche
11.14.1 Roche Company Details
11.14.2 Roche Business Overview
11.14.3 Roche Weight Loss Therapeutics Introduction
11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2020-2025)
11.14.5 Roche Recent Development
11.15 Eisai
11.15.1 Eisai Company Details
11.15.2 Eisai Business Overview
11.15.3 Eisai Weight Loss Therapeutics Introduction
11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2020-2025)
11.15.5 Eisai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Appetite Suppression
1.2.3 Increasing Body Metabolism
1.2.4 Interfering with the Digestion Absorption Patterns
1.3 Market by Application
1.3.1 Global Weight Loss Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Retail Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Weight Loss Therapeutics Market Perspective (2020-2031)
2.2 Global Weight Loss Therapeutics Growth Trends by Region
2.2.1 Global Weight Loss Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Weight Loss Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Weight Loss Therapeutics Market Dynamics
2.3.1 Weight Loss Therapeutics Industry Trends
2.3.2 Weight Loss Therapeutics Market Drivers
2.3.3 Weight Loss Therapeutics Market Challenges
2.3.4 Weight Loss Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Weight Loss Therapeutics Players by Revenue
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Weight Loss Therapeutics Revenue
3.4 Global Weight Loss Therapeutics Market Concentration Ratio
3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2024
3.5 Global Key Players of Weight Loss Therapeutics Head office and Area Served
3.6 Global Key Players of Weight Loss Therapeutics, Product and Application
3.7 Global Key Players of Weight Loss Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Weight Loss Therapeutics Breakdown Data by Type
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2026-2031)
5 Weight Loss Therapeutics Breakdown Data by Application
5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Weight Loss Therapeutics Market Size (2020-2031)
6.2 North America Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Weight Loss Therapeutics Market Size by Country (2020-2025)
6.4 North America Weight Loss Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Weight Loss Therapeutics Market Size (2020-2031)
7.2 Europe Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Weight Loss Therapeutics Market Size by Country (2020-2025)
7.4 Europe Weight Loss Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Weight Loss Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Weight Loss Therapeutics Market Size (2020-2031)
9.2 Latin America Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Weight Loss Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Weight Loss Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Weight Loss Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Weight Loss Therapeutics Introduction
11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Weight Loss Therapeutics Introduction
11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2020-2025)
11.3.5 Novo Nordisk Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2020-2025)
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Orexigen Therapeutics
11.5.1 Orexigen Therapeutics Company Details
11.5.2 Orexigen Therapeutics Business Overview
11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2020-2025)
11.5.5 Orexigen Therapeutics Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Weight Loss Therapeutics Introduction
11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Weight Loss Therapeutics Introduction
11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Biocon
11.9.1 Biocon Company Details
11.9.2 Biocon Business Overview
11.9.3 Biocon Weight Loss Therapeutics Introduction
11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2020-2025)
11.9.5 Biocon Recent Development
11.10 VIVUS
11.10.1 VIVUS Company Details
11.10.2 VIVUS Business Overview
11.10.3 VIVUS Weight Loss Therapeutics Introduction
11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2020-2025)
11.10.5 VIVUS Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2020-2025)
11.11.5 Eli Lilly Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Weight Loss Therapeutics Introduction
11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2020-2025)
11.12.5 Amgen Recent Development
11.13 Zafgen
11.13.1 Zafgen Company Details
11.13.2 Zafgen Business Overview
11.13.3 Zafgen Weight Loss Therapeutics Introduction
11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2020-2025)
11.13.5 Zafgen Recent Development
11.14 Roche
11.14.1 Roche Company Details
11.14.2 Roche Business Overview
11.14.3 Roche Weight Loss Therapeutics Introduction
11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2020-2025)
11.14.5 Roche Recent Development
11.15 Eisai
11.15.1 Eisai Company Details
11.15.2 Eisai Business Overview
11.15.3 Eisai Weight Loss Therapeutics Introduction
11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2020-2025)
11.15.5 Eisai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Appetite Suppression
Table 3. Key Players of Increasing Body Metabolism
Table 4. Key Players of Interfering with the Digestion Absorption Patterns
Table 5. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Weight Loss Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Weight Loss Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Weight Loss Therapeutics Market Share by Region (2020-2025)
Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Weight Loss Therapeutics Market Share by Region (2026-2031)
Table 11. Weight Loss Therapeutics Market Trends
Table 12. Weight Loss Therapeutics Market Drivers
Table 13. Weight Loss Therapeutics Market Challenges
Table 14. Weight Loss Therapeutics Market Restraints
Table 15. Global Weight Loss Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Weight Loss Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2024)
Table 18. Ranking of Global Top Weight Loss Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Weight Loss Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Weight Loss Therapeutics, Product and Application
Table 22. Global Key Players of Weight Loss Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Weight Loss Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Weight Loss Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Weight Loss Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Weight Loss Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Weight Loss Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Company Details
Table 48. Abbott Business Overview
Table 49. Abbott Weight Loss Therapeutics Product
Table 50. Abbott Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Sanofi Company Details
Table 53. Sanofi Business Overview
Table 54. Sanofi Weight Loss Therapeutics Product
Table 55. Sanofi Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Novo Nordisk Company Details
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Weight Loss Therapeutics Product
Table 60. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Arena Pharmaceuticals Company Details
Table 63. Arena Pharmaceuticals Business Overview
Table 64. Arena Pharmaceuticals Weight Loss Therapeutics Product
Table 65. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Arena Pharmaceuticals Recent Development
Table 67. Orexigen Therapeutics Company Details
Table 68. Orexigen Therapeutics Business Overview
Table 69. Orexigen Therapeutics Weight Loss Therapeutics Product
Table 70. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Orexigen Therapeutics Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Weight Loss Therapeutics Product
Table 75. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Weight Loss Therapeutics Product
Table 80. Pfizer Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Weight Loss Therapeutics Product
Table 85. Novartis AG Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Biocon Company Details
Table 88. Biocon Business Overview
Table 89. Biocon Weight Loss Therapeutics Product
Table 90. Biocon Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Biocon Recent Development
Table 92. VIVUS Company Details
Table 93. VIVUS Business Overview
Table 94. VIVUS Weight Loss Therapeutics Product
Table 95. VIVUS Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 96. VIVUS Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Weight Loss Therapeutics Product
Table 100. Eli Lilly Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Amgen Company Details
Table 103. Amgen Business Overview
Table 104. Amgen Weight Loss Therapeutics Product
Table 105. Amgen Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Amgen Recent Development
Table 107. Zafgen Company Details
Table 108. Zafgen Business Overview
Table 109. Zafgen Weight Loss Therapeutics Product
Table 110. Zafgen Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 111. Zafgen Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Weight Loss Therapeutics Product
Table 115. Roche Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Eisai Company Details
Table 118. Eisai Business Overview
Table 119. Eisai Weight Loss Therapeutics Product
Table 120. Eisai Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 121. Eisai Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Weight Loss Therapeutics Picture
Figure 2. Global Weight Loss Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Weight Loss Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Appetite Suppression Features
Figure 5. Increasing Body Metabolism Features
Figure 6. Interfering with the Digestion Absorption Patterns Features
Figure 7. Global Weight Loss Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Weight Loss Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Specialized Clinics Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Mail Order Pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Weight Loss Therapeutics Report Years Considered
Figure 15. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Weight Loss Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Weight Loss Therapeutics Market Share by Region: 2024 VS 2031
Figure 18. Global Weight Loss Therapeutics Market Share by Players in 2024
Figure 19. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2024
Figure 21. North America Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 23. United States Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 27. Germany Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Weight Loss Therapeutics Market Share by Region (2020-2031)
Figure 35. China Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 43. Mexico Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 47. Turkey Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 52. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 53. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 54. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 57. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 58. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 59. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 62. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 63. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 64. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Appetite Suppression
Table 3. Key Players of Increasing Body Metabolism
Table 4. Key Players of Interfering with the Digestion Absorption Patterns
Table 5. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Weight Loss Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Weight Loss Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Weight Loss Therapeutics Market Share by Region (2020-2025)
Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Weight Loss Therapeutics Market Share by Region (2026-2031)
Table 11. Weight Loss Therapeutics Market Trends
Table 12. Weight Loss Therapeutics Market Drivers
Table 13. Weight Loss Therapeutics Market Challenges
Table 14. Weight Loss Therapeutics Market Restraints
Table 15. Global Weight Loss Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Weight Loss Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2024)
Table 18. Ranking of Global Top Weight Loss Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Weight Loss Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Weight Loss Therapeutics, Product and Application
Table 22. Global Key Players of Weight Loss Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Weight Loss Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Weight Loss Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Weight Loss Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Weight Loss Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Weight Loss Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Weight Loss Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Company Details
Table 48. Abbott Business Overview
Table 49. Abbott Weight Loss Therapeutics Product
Table 50. Abbott Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Sanofi Company Details
Table 53. Sanofi Business Overview
Table 54. Sanofi Weight Loss Therapeutics Product
Table 55. Sanofi Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Novo Nordisk Company Details
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Weight Loss Therapeutics Product
Table 60. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Arena Pharmaceuticals Company Details
Table 63. Arena Pharmaceuticals Business Overview
Table 64. Arena Pharmaceuticals Weight Loss Therapeutics Product
Table 65. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Arena Pharmaceuticals Recent Development
Table 67. Orexigen Therapeutics Company Details
Table 68. Orexigen Therapeutics Business Overview
Table 69. Orexigen Therapeutics Weight Loss Therapeutics Product
Table 70. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Orexigen Therapeutics Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Weight Loss Therapeutics Product
Table 75. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Weight Loss Therapeutics Product
Table 80. Pfizer Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Weight Loss Therapeutics Product
Table 85. Novartis AG Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Biocon Company Details
Table 88. Biocon Business Overview
Table 89. Biocon Weight Loss Therapeutics Product
Table 90. Biocon Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Biocon Recent Development
Table 92. VIVUS Company Details
Table 93. VIVUS Business Overview
Table 94. VIVUS Weight Loss Therapeutics Product
Table 95. VIVUS Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 96. VIVUS Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Weight Loss Therapeutics Product
Table 100. Eli Lilly Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Amgen Company Details
Table 103. Amgen Business Overview
Table 104. Amgen Weight Loss Therapeutics Product
Table 105. Amgen Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Amgen Recent Development
Table 107. Zafgen Company Details
Table 108. Zafgen Business Overview
Table 109. Zafgen Weight Loss Therapeutics Product
Table 110. Zafgen Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 111. Zafgen Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Weight Loss Therapeutics Product
Table 115. Roche Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Eisai Company Details
Table 118. Eisai Business Overview
Table 119. Eisai Weight Loss Therapeutics Product
Table 120. Eisai Revenue in Weight Loss Therapeutics Business (2020-2025) & (US$ Million)
Table 121. Eisai Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Weight Loss Therapeutics Picture
Figure 2. Global Weight Loss Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Weight Loss Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Appetite Suppression Features
Figure 5. Increasing Body Metabolism Features
Figure 6. Interfering with the Digestion Absorption Patterns Features
Figure 7. Global Weight Loss Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Weight Loss Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Specialized Clinics Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Mail Order Pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Weight Loss Therapeutics Report Years Considered
Figure 15. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Weight Loss Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Weight Loss Therapeutics Market Share by Region: 2024 VS 2031
Figure 18. Global Weight Loss Therapeutics Market Share by Players in 2024
Figure 19. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss Therapeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2024
Figure 21. North America Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 23. United States Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 27. Germany Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Weight Loss Therapeutics Market Share by Region (2020-2031)
Figure 35. China Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 43. Mexico Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Weight Loss Therapeutics Market Share by Country (2020-2031)
Figure 47. Turkey Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Weight Loss Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 52. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 53. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 54. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 57. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 58. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 59. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 62. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 63. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 64. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232